Featured CME Programs

 

 

24FC112-GU-CME-graphics-1_Site-Thum

Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education.

The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. This CME program is designed to address the challenges physicians face in treating these complex cases.

Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.

DATE
Wednesday, November 20th, 2024

Register

Attached Flyer

TIMES
6:00 pm - 9:00 pm

 

PROGRAM DIRECTORS

Kutikov_Official Headsho

Alexander Kutikov, MD, FACS 
Chair and Professor, Department of Urology 
Roberta R. Scheller Chair in Urologic Oncology
Fox Chase – Temple Urologic Institute Provider 

Geynisman Daniel

Daniel M. Geynisman, MD 
Chief, Division of Genitourinary Medical Oncology 
Associate Professor, Department of Hematology/Oncology

TOPICS & PRESENTERS:

Mark-Ryan

J. Ryan Mark, MD, FACS 
Advanced Surgical Techniques for Genitourinary Cancers 

Wong-JKWheadshot1

Jessica Karen Wong, MD, MEng 
SABR for Oligometastatic Prostate Cancer and Localized Kidney Cancer 

Pooja

Pooja Ghatalia, MD
Nuances and Options for the Management of Advanced Bladder Cancer

Anari-Fern

Fern Anari, MD 
Biochemically Recurrent Prostate Cancer: Treatment Paradigms and New Options 

MatthewZibelman

Matthew R. Zibelman, MD 
Adjuvant therapy in Renal Cell Carcinoma

Inquiries

Lucía Tono, PhD
Med: 215-728-3797 
[email protected]

Intended Audience

Medical, surgical and radiation oncologists; thoracic and general surgeons; pulmonologists; gastroenterologists; pathologists; radiologists; fellows/residents/ students; nurses; physician assistants; pharmacists; researchers; and advanced practice clinicians involved in the management of patients with lung cancer and thoracic malignancies.

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 4 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.

 

Lung-CME-SABC

23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.

REGISTER NOW: 

https://www.eeds.com/live/478307

NEW THIS YEAR: POSTER SESSION AND AWARDS

We invite students, residents, fellows, and faculty (less than 5 years from completing their training) to submit abstracts on basic science, translational research, or clinical research in breast cancer.

To submit an abstract for consideration, please send the following by Monday,December 2, 2024, to [email protected]:

1. One–page abstract (maximum 500 words), please structure your abstract as follows: Title, Background/Introduction, Objectives, Methods, Results and Conclusions

2. In the abstract, please specify the name, credential, affiliation and e-mail of the person that will be presenting the poster. Priority will be given to early abstract submissions. Notifications of abstracts selected will be done by email.

PROGRAM DATE: Thursday, January 30, 2025

TIMES: 

5:45–7:00 pm EST Check-In, Reception and Poster Session
(Buffet opens at 6:30) 
7:00–9:00 pm EST CME & Dinner

LOCATION: 

Philadelphia Marriott Old City 
One Dock Street 
Philadelphia, PA 19106

LEARNING OBJECTIVES:

Analyze the advances in the management of breast cancer and premalignant breast disease and when clinically relevant: 
Integrate new findings into the management of these patients.

Apply new strategies for optimizing existing treatments into the management of these patients. 
Analyze new developments in breast cancer research and current available clinical trials and when clinically relevant, include this information in discussions with patients.

 

PROGRAM DIRECTOR & FACULTY: 

Jain-Angela


Angela Jain, MD 
Associate Professor, 
Department of Hematology/Oncology; 
Interim Chief, Division of Breast Medical Oncology; 
Clinical Director, GYN/Well Women's Health Clinical Service Line
Chief, Division of Gynecologic Medical Oncology; 
Fox Chase Cancer Center

PLANNING COMMITTEE: 

Seidman Michael


Michael Seidman, MD 
Professor, Department of Hematology/Oncology 
Fox Chase Cancer Center

Click Here for Program Flyer

INTENDED AUDIENCE: The program is designed for medical, surgical, and radiation oncologists; gynecologists; radiologists; fellows; residents; medical school students; advanced practice providers; nurses; and healthcare professionals involved in the treatment of patients with breast cancer.

ACCREDITATION STATEMENT The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

DESIGNATION STATEMENT The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 2 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.

INQUIRIES: Lucía Tono, PhD, MEd 215-728-3797 
[email protected]

REGISTER NOW: https://www.eeds.com/live/478307

Resize Text

Upcoming CME Events

Disclosure Policy

It is the policy of the Temple Health Office for Continuing Medical Education to ensure that all sponsored continuing medical education activities are independently designed and produced and include content that is valid, objective, balanced, free of commercial bias and in the best interest to the public. Temple Health policy requires everyone in a position to control the content of an educational activity to disclose all financial relationships with ineligible companies and to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). The Temple Health Office for Continuing Medical Education has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the activity.